EMTRO XR 10/5/1000MG 14s TAB

Product Name & Composition

• Emtro XR 10 mg + 5 mg + 1000 mg Tablets (pack of 14)

• A triple-agent extended‑release oral tablet containing:

  • Empagliflozin 10 mg

  • Linagliptin 5 mg

  • Metformin HCl 1000 mg
    
    

🏭 Manufacturer

• Produced and marketed by Searle Pakistan (Pvt) Ltd.
  

🩺 Indication & Use

• Prescribed for Type 2 Diabetes Mellitus.

• Designed to be taken once daily with meals.

• Works via three complementary mechanisms:

  • Metformin: Lowers hepatic glucose production and increases insulin sensitivity.

  • Empagliflozin: Promotes glucose excretion via the kidneys.

  • Linagliptin: Enhances insulin secretion and suppresses glucagon via incretin pathway.